B9D2
geneOn this page
Also known as MGC4093MKS10MKSR-2
Summary
B9D2 (B9 domain containing 2, HGNC:28636) is a protein-coding gene on chromosome 19q13.2, encoding B9 domain-containing protein 2 (Q9BPU9). Component of the tectonic-like complex, a complex localized at the transition zone of primary cilia and acting as a barrier that prevents diffusion of transmembrane proteins between the cilia and plasma membranes.
This gene encodes a B9 domain protein, which are exclusively found in ciliated organisms. The gene is upregulated during mucociliary differentiation, and the encoded protein localizes to basal bodies and cilia. Disrupting expression of this gene results in ciliogenesis defects.
Source: NCBI Gene 80776 — RefSeq curated summary.
At a glance
- Gene–disease (curated): Meckel syndrome, type 10 (Strong, GenCC) — +2 more curated relationships
- GWAS associations: 9
- Clinical variants (ClinVar): 111 total — 2 pathogenic, 5 likely-pathogenic
- Phenotypes (HPO): 96
- MANE Select transcript:
NM_030578
Identifiers
Gene identifiers
| Field | Value |
|---|---|
| HGNC ID | HGNC:28636 |
| Approved symbol | B9D2 |
| Name | B9 domain containing 2 |
| Location | 19q13.2 |
| Locus type | gene with protein product |
| Status | Approved |
| Aliases | MGC4093, MKS10, MKSR-2 |
| Ensembl gene | ENSG00000123810 |
| Ensembl biotype | protein_coding |
| OMIM | 611951 |
| Entrez | 80776 |
Gene structure
Transcript identifiers
Ensembl transcripts: 9 — 7 protein_coding, 1 nonsense_mediated_decay, 1 protein_coding_CDS_not_defined
ENST00000243578, ENST00000594416, ENST00000601597, ENST00000675972, ENST00000890348, ENST00000890349, ENST00000890350, ENST00000890351, ENST00000932334
RefSeq mRNA: 1 — MANE Select: NM_030578
NM_030578
CCDS: CCDS12579
Canonical transcript exons
ENST00000243578 — 4 exons
| Exon | Start | End |
|---|---|---|
| ENSE00000842443 | 41354417 | 41355013 |
| ENSE00001052862 | 41363958 | 41364149 |
| ENSE00003465514 | 41357897 | 41358022 |
| ENSE00003572078 | 41363432 | 41363523 |
Expression profiles
Bgee: expression breadth ubiquitous, 138 present calls, max score 88.51.
FANTOM5 (CAGE): breadth ubiquitous, TPM avg 4.7303 / max 77.5624, expressed in 1642 samples.
FANTOM5 promoters (2 alternative TSS)
| Promoter ID | TPM avg | Samples expressed |
|---|---|---|
| 181057 | 3.4251 | 1547 |
| 181056 | 1.3052 | 562 |
Top tissues by expression
138 total, by Bgee expression score (0-100, higher = more expressed):
| Tissue | Anatomy ID | Expression score | Quality |
|---|---|---|---|
| right uterine tube | UBERON:0001302 | 88.51 | gold quality |
| blood | UBERON:0000178 | 88.48 | gold quality |
| olfactory segment of nasal mucosa | UBERON:0005386 | 85.90 | gold quality |
| granulocyte | CL:0000094 | 83.77 | gold quality |
| primordial germ cell in gonad | CL:0000670 ∩ UBERON:0000991 | 83.66 | gold quality |
| monocyte | CL:0000576 | 83.65 | gold quality |
| leukocyte | CL:0000738 | 83.53 | gold quality |
| male germ line stem cell (sensu Vertebrata) in testis | CL:0000089 ∩ UBERON:0000473 | 82.68 | gold quality |
| right adrenal gland | UBERON:0001233 | 81.54 | gold quality |
| fallopian tube | UBERON:0003889 | 81.53 | gold quality |
| bone marrow | UBERON:0002371 | 81.35 | gold quality |
| right adrenal gland cortex | UBERON:0035827 | 80.76 | gold quality |
| left adrenal gland | UBERON:0001234 | 80.42 | gold quality |
| mucosa of transverse colon | UBERON:0004991 | 80.20 | gold quality |
| left adrenal gland cortex | UBERON:0035825 | 79.92 | gold quality |
| adult mammalian kidney | UBERON:0000082 | 79.40 | gold quality |
| spleen | UBERON:0002106 | 79.38 | gold quality |
| metanephros cortex | UBERON:0010533 | 78.59 | gold quality |
| muscle layer of sigmoid colon | UBERON:0035805 | 78.56 | gold quality |
| lower esophagus muscularis layer | UBERON:0035833 | 78.43 | gold quality |
| lower esophagus | UBERON:0013473 | 78.39 | gold quality |
| adrenal gland | UBERON:0002369 | 78.08 | gold quality |
| left uterine tube | UBERON:0001303 | 77.94 | gold quality |
| esophagogastric junction muscularis propria | UBERON:0035841 | 77.92 | gold quality |
| body of uterus | UBERON:0009853 | 77.81 | gold quality |
| myometrium | UBERON:0001296 | 77.73 | gold quality |
| cortex of kidney | UBERON:0001225 | 77.44 | gold quality |
| body of stomach | UBERON:0001161 | 77.02 | gold quality |
| right lobe of thyroid gland | UBERON:0001119 | 76.96 | gold quality |
| transverse colon | UBERON:0001157 | 76.89 | gold quality |
Single-cell (SCXA)
Detected in 2 experiment(s), a significant marker in 2.
| Experiment | Marker? | Max mean expression |
|---|---|---|
| E-CURD-114 | yes | 11.16 |
| E-ANND-3 | yes | 5.16 |
Regulation
Is transcription factor: no
miRNA regulators (miRDB)
6 targeting B9D2, top 30 by miRDB confidence (max_score; target_count = how many genes the miRNA targets in total — lower means more specific):
| miRNA | Max score | Avg score | miRNA target_count |
|---|---|---|---|
| HSA-MIR-6737-3P | 98.95 | 68.56 | 1577 |
| HSA-MIR-7157-3P | 98.95 | 68.70 | 1582 |
| HSA-MIR-6889-3P | 98.84 | 67.35 | 1198 |
| HSA-MIR-5008-3P | 98.73 | 67.50 | 1433 |
| HSA-MIR-6529-3P | 98.68 | 66.76 | 1020 |
| HSA-MIR-3691-5P | 98.62 | 65.88 | 552 |
Literature-anchored findings (GeneRIF, showing 5)
- ICIS-1 is a new protein associated with ciliated cells and potentially related to cilia stability. This gene is localized within the TGF-beta1 promoter and is ubiquitously expressed in human tissues. (PMID:17127412)
- The ICIS-1 (Involved in CIlia Stability-1)gene is localized within the TGF-beta1 promoter and is upregulated during mucociliary differentiation. (PMID:17127412)
- MKS-1 and MKS-1-related proteins 1 and 2 (MKSR-1/EPPB9, MKSR-2/B9D2), localize to transition zones/basal bodies of sensory cilia; subcellular localization is largely co-dependent, pointing to a functional relationship between the proteins (PMID:19208769)
- Formation of the B9-domain protein complex MKS1-B9D2-B9D1 is essential as a diffusion barrier for ciliary membrane proteins. (PMID:32726168)
- New functions of B9D2 in tight junctions and epithelial polarity. (PMID:39455645)
Cross-species orthologs
5 orthologs
| Organism | Symbol | Gene ID |
|---|---|---|
| danio_rerio | b9d2 | ENSDARG00000017385 |
| mus_musculus | B9d2 | ENSMUSG00000063439 |
| rattus_norvegicus | B9d2 | ENSRNOG00000028753 |
| drosophila_melanogaster | B9d2 | FBGN0261683 |
| caenorhabditis_elegans | WBGENE00021416 |
Paralogs (2): MKS1 (ENSG00000011143), B9D1 (ENSG00000108641)
Protein
Protein identifiers
B9 domain-containing protein 2 — Q9BPU9 (reviewed: Q9BPU9)
Alternative names: MKS1-related protein 2
All UniProt accessions (2): Q9BPU9, M0QY88
UniProt curated annotations — full annotation on UniProt →
Function. Component of the tectonic-like complex, a complex localized at the transition zone of primary cilia and acting as a barrier that prevents diffusion of transmembrane proteins between the cilia and plasma membranes.
Subunit / interactions. Part of the tectonic-like complex (also named B9 complex). Interacts with TUBG1.
Subcellular location. Cytoplasm. Cytoskeleton. Cilium basal body. Cilium axoneme. Nucleus.
Disease relevance. Meckel syndrome 10 (MKS10) [MIM:614175] A disorder characterized by a combination of renal cysts and variably associated features including developmental anomalies of the central nervous system (typically encephalocele), hepatic ductal dysplasia and cysts, and polydactyly. The disease is caused by variants affecting the gene represented in this entry. Joubert syndrome 34 (JBTS34) [MIM:614175] A form of Joubert syndrome, a disorder presenting with cerebellar ataxia, oculomotor apraxia, hypotonia, neonatal breathing abnormalities and psychomotor delay. Neuroradiologically, it is characterized by cerebellar vermian hypoplasia/aplasia, thickened and reoriented superior cerebellar peduncles, and an abnormally large interpeduncular fossa, giving the appearance of a molar tooth on transaxial slices (molar tooth sign). Additional variable features include retinal dystrophy, renal disease, liver fibrosis, and polydactyly. JBTS34 inheritance is autosomal recessive. The disease is caused by variants affecting the gene represented in this entry.
Similarity. Belongs to the B9D family.
RefSeq proteins (1): NP_085055* (*=MANE)
Domains & families (InterPro)
| ID | Name | Type |
|---|---|---|
| IPR010796 | C2_B9-type_dom | Family |
Pfam: PF07162
UniProt features (8 total): sequence variant 6, chain 1, domain 1
Structure
Experimental structures (PDB)
0 structures.
Predicted structure (AlphaFold)
| Model | pLDDT | Fraction very-high |
|---|---|---|
| AF-Q9BPU9-F1 | 89.79 | 0.65 |
Function
Pathways and Gene Ontology
Reactome pathways
21 pathways
| ID | Pathway |
|---|---|
| R-HSA-141444 | Amplification of signal from unattached kinetochores via a MAD2 inhibitory signal |
| R-HSA-2467813 | Separation of Sister Chromatids |
| R-HSA-2500257 | Resolution of Sister Chromatid Cohesion |
| R-HSA-5620912 | Anchoring of the basal body to the plasma membrane |
| R-HSA-5663220 | RHO GTPases Activate Formins |
| R-HSA-68877 | Mitotic Prometaphase |
| R-HSA-9648025 | EML4 and NUDC in mitotic spindle formation |
| R-HSA-141424 | Amplification of signal from the kinetochores |
| R-HSA-162582 | Signal Transduction |
| R-HSA-1640170 | Cell Cycle |
| R-HSA-1852241 | Organelle biogenesis and maintenance |
| R-HSA-194315 | Signaling by Rho GTPases |
| R-HSA-195258 | RHO GTPase Effectors |
| R-HSA-2555396 | Mitotic Metaphase and Anaphase |
| R-HSA-5617833 | Cilium Assembly |
| R-HSA-68882 | Mitotic Anaphase |
| R-HSA-68886 | M Phase |
| R-HSA-69278 | Cell Cycle, Mitotic |
| R-HSA-69618 | Mitotic Spindle Checkpoint |
| R-HSA-69620 | Cell Cycle Checkpoints |
| R-HSA-9716542 | Signaling by Rho GTPases, Miro GTPases and RHOBTB3 |
MSigDB gene sets: 330 (showing top):
GOBP_PROTEIN_LOCALIZATION_TO_CILIUM, GRAESSMANN_APOPTOSIS_BY_DOXORUBICIN_DN, GOCC_MICROTUBULE_ORGANIZING_CENTER, GOBP_CILIUM_ORGANIZATION, GOCC_CENTROSOME, GOBP_ORGANELLE_ASSEMBLY, GGCKCATGS_UNKNOWN, GOBP_PROTEIN_LOCALIZATION_TO_ORGANELLE, RFX1_02, GOBP_CELL_PROJECTION_ORGANIZATION, TGTYNNNNNRGCARM_UNKNOWN, REACTOME_CELL_CYCLE_CHECKPOINTS, GOCC_CYTOPLASMIC_REGION, GOCC_CILIARY_TRANSITION_ZONE, MARSON_BOUND_BY_FOXP3_UNSTIMULATED
GO Biological Process (2): cilium assembly (GO:0060271), cell projection organization (GO:0030030)
GO Molecular Function (2): gamma-tubulin binding (GO:0043015), protein binding (GO:0005515)
GO Cellular Component (12): nucleus (GO:0005634), centrosome (GO:0005813), cytosol (GO:0005829), axoneme (GO:0005930), membrane (GO:0016020), MKS complex (GO:0036038), ciliary basal body (GO:0036064), cytoplasm (GO:0005737), cytoskeleton (GO:0005856), cilium (GO:0005929), ciliary transition zone (GO:0035869), cell projection (GO:0042995)
Reactome top-level categories
Rollup of top-14 pathways:
| Category | Pathways |
|---|---|
| Mitotic Prometaphase | 2 |
| M Phase | 2 |
| Cell Cycle | 2 |
| Amplification of signal from the kinetochores | 1 |
| Mitotic Anaphase | 1 |
| Assembly of the 9+0 primary cilium | 1 |
| RHO GTPase Effectors | 1 |
| Mitotic Spindle Checkpoint | 1 |
| Signaling by Rho GTPases, Miro GTPases and RHOBTB3 | 1 |
| Signaling by Rho GTPases | 1 |
| Organelle biogenesis and maintenance | 1 |
| Mitotic Metaphase and Anaphase | 1 |
| Cell Cycle, Mitotic | 1 |
| Cell Cycle Checkpoints | 1 |
GO top-level categories
Rollup of top GO terms by namespace:
| Category | Terms |
|---|---|
| cellular anatomical structure | 6 |
| microtubule organizing center | 2 |
| cilium | 2 |
| axoneme assembly | 1 |
| intraciliary transport involved in cilium assembly | 1 |
| cilium organization | 1 |
| protein localization to cilium | 1 |
| organelle assembly | 1 |
| trans-Golgi to periciliary membrane compartment transport | 1 |
| plasma membrane bounded cell projection assembly | 1 |
| ciliary transition zone assembly | 1 |
| cellular component organization | 1 |
| tubulin binding | 1 |
| binding | 1 |
| intracellular membrane-bounded organelle | 1 |
| centriole | 1 |
| cytoplasm | 1 |
| cytoskeleton | 1 |
| microtubule | 1 |
| ciliary plasm | 1 |
| protein-containing complex | 1 |
| ciliary transition zone | 1 |
| intracellular anatomical structure | 1 |
| intracellular membraneless organelle | 1 |
| intraciliary transport particle | 1 |
| membrane-bounded organelle | 1 |
| plasma membrane bounded cell projection | 1 |
Protein interactions and networks
STRING
650 interactions, top by confidence (×1000):
| Protein A | Protein B | Partner UniProt | Score |
|---|---|---|---|
| B9D2 | TMEM67 | Q5HYA8 | 975 |
| B9D2 | CC2D2A | Q9P2K1 | 969 |
| B9D2 | TMEM216 | Q9P0N5 | 966 |
| B9D2 | B9D1 | Q9UPM9 | 959 |
| B9D2 | TCTN1 | Q2MV58 | 953 |
| B9D2 | TCTN2 | Q96GX1 | 949 |
| B9D2 | TMEM231 | Q9H6L2 | 943 |
| B9D2 | CEP290 | O15078 | 895 |
| B9D2 | TCTN3 | Q6NUS6 | 895 |
| B9D2 | NPHP1 | O15259 | 886 |
| B9D2 | NPHP4 | O75161 | 883 |
| B9D2 | TMEM237 | Q96Q45 | 854 |
| B9D2 | AHI1 | Q8N157 | 842 |
| B9D2 | RPGRIP1L | Q68CZ1 | 828 |
| B9D2 | TMEM17 | Q86X19 | 826 |
IntAct
53 interactions, top by confidence:
| A | B | Type | Score |
|---|---|---|---|
| B9D2 | B9D1 | psi-mi:“MI:0915”(physical association) | 0.840 |
| B9D2 | TMEM231 | psi-mi:“MI:0914”(association) | 0.730 |
| B9D2 | MKS1 | psi-mi:“MI:0915”(physical association) | 0.730 |
| MKS1 | B9D2 | psi-mi:“MI:0915”(physical association) | 0.730 |
| INVS | B9D2 | psi-mi:“MI:0407”(direct interaction) | 0.590 |
| INVS | B9D2 | psi-mi:“MI:0915”(physical association) | 0.590 |
| B9D2 | INVS | psi-mi:“MI:0915”(physical association) | 0.590 |
| SPAG8 | B9D2 | psi-mi:“MI:0915”(physical association) | 0.560 |
| SAXO4 | B9D2 | psi-mi:“MI:0915”(physical association) | 0.560 |
| P4HA3 | B9D2 | psi-mi:“MI:0915”(physical association) | 0.560 |
| B9D2 | VPS25 | psi-mi:“MI:0915”(physical association) | 0.560 |
| TLX3 | B9D2 | psi-mi:“MI:0915”(physical association) | 0.560 |
| B9D2 | ALKBH7 | psi-mi:“MI:0915”(physical association) | 0.560 |
| PLEKHA7 | B9D2 | psi-mi:“MI:0915”(physical association) | 0.560 |
| QARS1 | B9D2 | psi-mi:“MI:0915”(physical association) | 0.560 |
| B9D2 | ANKRD40 | psi-mi:“MI:0914”(association) | 0.530 |
| IFT70B | B9D2 | psi-mi:“MI:0407”(direct interaction) | 0.530 |
| B9D2 | IFT70B | psi-mi:“MI:0915”(physical association) | 0.530 |
| CC2D2A | OFD1 | psi-mi:“MI:2364”(proximity) | 0.420 |
| INVS | IFT70B | psi-mi:“MI:0915”(physical association) | 0.400 |
| TCTN1 | PPOX | psi-mi:“MI:0914”(association) | 0.350 |
| TMEM231 | TNFRSF10B | psi-mi:“MI:0914”(association) | 0.350 |
| B9D2 | PARN | psi-mi:“MI:0914”(association) | 0.350 |
| TCTN1 | GUSB | psi-mi:“MI:0914”(association) | 0.350 |
| TCTN1 | NPTX1 | psi-mi:“MI:0914”(association) | 0.350 |
BioGRID (83): B9D2 (Affinity Capture-MS), ANP32A (Proximity Label-MS), ARID1B (Proximity Label-MS), B9D1 (Proximity Label-MS), BCOR (Proximity Label-MS), CNOT7 (Proximity Label-MS), CPSF7 (Proximity Label-MS), DCAF7 (Proximity Label-MS), DNMT1 (Proximity Label-MS), EIF4ENIF1 (Proximity Label-MS), FAM208A (Proximity Label-MS), FUBP3 (Proximity Label-MS), GRIP1 (Proximity Label-MS), HNRNPM (Proximity Label-MS), IBTK (Proximity Label-MS)
ESM2 similar proteins: A3QVV1, A7KAI6, B0JYW5, B0X2G0, B3M123, B3MZN7, B3NY19, B4JGX4, B4LZ60, B4NJR8, B4P925, B4PUG5, B4PYH5, B4QVL3, B5MCN3, M9MRD5, O08688, O15484, O88796, P0C5J2, P0C5J3, P78346, P78963, Q09541, Q22036, Q3SZ21, Q3UK10, Q503B7, Q56JY9, Q5BJ61, Q5S1W2, Q5XQC7, Q623S8, Q68EZ3, Q6DFD7, Q6DGZ1, Q6GN70, Q756G8, Q7QD36, Q8R4C0
Diamond homologs: M9MRD5, P0C5J3, Q3UK10, Q499Q5, Q56JY9, Q5SW45, Q6DGZ1, Q6GN70, Q9BPU9, Q9NXB0
SIGNOR signaling
0 interactions.
Enriched among interaction partners
Reactome pathways and GO biological processes over-represented among this gene’s 26 IntAct physical interaction partners (hypergeometric vs the genome-wide background, BH-FDR, gene-set size 15–500, ranked by fold). A functional readout of the neighbourhood — distinct from this gene’s own memberships above, and biased toward well-studied / hub proteins, so read it as themes rather than proof.
Reactome pathways:
| Pathway | Partners | Fold | FDR |
|---|---|---|---|
| Anchoring of the basal body to the plasma membrane | 5 | 35.3× | 1e-05 |
| Cilium Assembly | 5 | 34.0× | 1e-05 |
| Organelle biogenesis and maintenance | 5 | 20.6× | 8e-05 |
GO biological processes:
| GO term | Partners | Fold | FDR |
|---|---|---|---|
| cilium assembly | 7 | 20.6× | 5e-06 |
Disease & clinical
Clinical variants and AI predictions
ClinVar
111 variants total. Per-class counts are floors (≥ shown; pagination cap):
| Classification | Count (floor) |
|---|---|
| Pathogenic | 2 |
| Likely pathogenic | 5 |
| Uncertain significance | 50 |
| Likely benign | 32 |
| Benign | 10 |
Top pathogenic / likely-pathogenic (7)
| Variant ID | HGVS | Classification |
|---|---|---|
| 217557 | NM_030578.4(B9D2):c.107T>C (p.Leu36Pro) | Pathogenic |
| 30931 | NM_030578.4(B9D2):c.301A>C (p.Ser101Arg) | Pathogenic |
| 2501262 | NM_030578.4(B9D2):c.223_224insT (p.Arg75fs) | Likely pathogenic |
| 2501263 | NM_030578.4(B9D2):c.33delinsTG (p.Ala13fs) | Likely pathogenic |
| 4531724 | NM_030578.4(B9D2):c.127C>T (p.Gln43Ter) | Likely pathogenic |
| 684427 | NM_030578.4(B9D2):c.15C>A (p.His5Gln) | Likely pathogenic |
| 812149 | NM_030578.4(B9D2):c.168C>G (p.Tyr56Ter) | Likely pathogenic |
SpliceAI
711 predictions. Top by Δscore:
| Variant | Effect | Δscore |
|---|---|---|
| 19:41357892:CCCA:C | donor_loss | 1.0000 |
| 19:41357893:CCA:C | donor_loss | 1.0000 |
| 19:41357894:CA:C | donor_loss | 1.0000 |
| 19:41357895:ACCTT:A | donor_loss | 1.0000 |
| 19:41357896:C:A | donor_loss | 1.0000 |
| 19:41361128:G:C | donor_gain | 1.0000 |
| 19:41363971:A:C | donor_gain | 1.0000 |
| 19:41357899:TGAAG:T | donor_gain | 0.9900 |
| 19:41363467:T:A | donor_gain | 0.9900 |
| 19:41363956:AC:A | donor_loss | 0.9900 |
| 19:41363957:CCTT:C | donor_loss | 0.9900 |
| 19:41363970:A:AC | donor_gain | 0.9900 |
| 19:41364111:T:TA | donor_gain | 0.9900 |
| 19:41355009:CCAGC:C | acceptor_gain | 0.9800 |
| 19:41355010:CAGCC:C | acceptor_gain | 0.9800 |
| 19:41355013:CCTG:C | acceptor_loss | 0.9800 |
| 19:41355014:C:CC | acceptor_gain | 0.9800 |
| 19:41355014:CT:C | acceptor_loss | 0.9800 |
| 19:41355015:T:G | acceptor_loss | 0.9800 |
| 19:41358018:CGCCC:C | acceptor_gain | 0.9800 |
| 19:41358019:GCCCC:G | acceptor_loss | 0.9800 |
| 19:41358022:CCT:C | acceptor_loss | 0.9800 |
| 19:41358023:CTGC:C | acceptor_loss | 0.9800 |
| 19:41358024:T:A | acceptor_loss | 0.9800 |
| 19:41363995:A:AT | donor_gain | 0.9800 |
| 19:41364027:T:TA | donor_gain | 0.9800 |
| 19:41355010:CAGC:C | acceptor_gain | 0.9700 |
| 19:41355011:AGC:A | acceptor_gain | 0.9700 |
| 19:41355012:GC:G | acceptor_gain | 0.9700 |
| 19:41355013:CC:C | acceptor_gain | 0.9700 |
AlphaMissense
1135 scored. Top likely-pathogenic:
| Variant | Protein change | am_pathogenicity |
|---|---|---|
| 19:41358014:A:G | W33R | 0.999 |
| 19:41358014:A:T | W33R | 0.999 |
| 19:41354944:C:T | G95E | 0.998 |
| 19:41355011:A:G | W73R | 0.998 |
| 19:41355011:A:T | W73R | 0.998 |
| 19:41357942:A:G | W57R | 0.998 |
| 19:41357942:A:T | W57R | 0.998 |
| 19:41357980:G:T | T44K | 0.997 |
| 19:41358012:C:A | W33C | 0.997 |
| 19:41358012:C:G | W33C | 0.997 |
| 19:41363451:G:C | C23W | 0.997 |
| 19:41363497:C:T | G8E | 0.997 |
| 19:41354889:C:A | W113C | 0.996 |
| 19:41354889:C:G | W113C | 0.996 |
| 19:41354891:A:G | W113R | 0.996 |
| 19:41354891:A:T | W113R | 0.996 |
| 19:41363447:A:G | W25R | 0.996 |
| 19:41363447:A:T | W25R | 0.996 |
| 19:41363453:A:G | C23R | 0.996 |
| 19:41354977:T:A | D84V | 0.995 |
| 19:41355007:G:T | P74H | 0.995 |
| 19:41357929:A:T | I61N | 0.995 |
| 19:41357980:G:C | T44R | 0.995 |
| 19:41363452:C:T | C23Y | 0.995 |
| 19:41363498:C:A | G8W | 0.995 |
| 19:41354945:C:G | G95R | 0.994 |
| 19:41354945:C:T | G95R | 0.994 |
| 19:41363472:G:C | F16L | 0.994 |
| 19:41363472:G:T | F16L | 0.994 |
| 19:41363474:A:G | F16L | 0.994 |
dbSNP variants (sampled 300 via entrez): RS1000123002 (19:41357866 G>A), RS1000244786 (19:41359860 C>A,T), RS1000405912 (19:41357604 G>A), RS1000438828 (19:41354191 G>A), RS1000722238 (19:41359627 C>T), RS1000751328 (19:41363917 C>A,G,T), RS1001044338 (19:41365110 T>A), RS1001473424 (19:41355221 A>G), RS1001651288 (19:41361470 C>T), RS1002083193 (19:41358220 C>A,T), RS1002187622 (19:41366083 C>A,T), RS1002262750 (19:41362078 C>A), RS1002859308 (19:41365331 C>T), RS1002911678 (19:41365519 C>G), RS1003312364 (19:41360284 T>C)
Disease associations
OMIM: gene MIM:611951 | disease phenotypes: MIM:213300, MIM:249000, MIM:614175
GenCC curated gene-disease
| Disease | Classification | Inheritance |
|---|---|---|
| Meckel syndrome, type 10 | Strong | Autosomal recessive |
| ciliopathy | Strong | Autosomal recessive |
| Meckel syndrome | Supportive | Autosomal recessive |
ClinGen Gene-Disease Validity (1)
Expert-panel classifications — Definitive > Strong > Moderate > Limited > Disputed > Refuted.
| Disease | Classification | Inheritance |
|---|---|---|
| ciliopathy | Moderate | AR |
Mondo (6): Joubert syndrome (MONDO:0018772), Meckel syndrome (MONDO:0018921), Meckel syndrome, type 10 (MONDO:0013609), ciliopathy (MONDO:0005308), Joubert syndrome and related disorders (MONDO:0015369), Joubert syndrome 34 (MONDO:0800383)
Orphanet (4): Isolated Joubert syndrome (Orphanet:475), Meckel syndrome (Orphanet:564), Ciliopathy (Orphanet:363250), Joubert syndrome and related disorders (Orphanet:140874)
HPO phenotypes
96 total (30 of 96 shown, HPO-id order):
| HPO | Term |
|---|---|
| HP:0000003 | Multicystic kidney dysplasia |
| HP:0000007 | Autosomal recessive inheritance |
| HP:0000028 | Cryptorchidism |
| HP:0000037 | Male pseudohermaphroditism |
| HP:0000047 | Hypospadias |
| HP:0000054 | Micropenis |
| HP:0000062 | Ambiguous genitalia |
| HP:0000068 | Urethral atresia |
| HP:0000073 | Ureteral duplication |
| HP:0000107 | Renal cyst |
| HP:0000175 | Cleft palate |
| HP:0000193 | Bifid uvula |
| HP:0000202 | Orofacial cleft |
| HP:0000221 | Furrowed tongue |
| HP:0000238 | Hydrocephalus |
| HP:0000252 | Microcephaly |
| HP:0000276 | Long face |
| HP:0000286 | Epicanthus |
| HP:0000293 | Full cheeks |
| HP:0000316 | Hypertelorism |
| HP:0000340 | Sloping forehead |
| HP:0000347 | Micrognathia |
| HP:0000358 | Posteriorly rotated ears |
| HP:0000369 | Low-set ears |
| HP:0000377 | Abnormal pinna morphology |
| HP:0000426 | Prominent nasal bridge |
| HP:0000457 | Depressed nasal ridge |
| HP:0000463 | Anteverted nares |
| HP:0000482 | Microcornea |
| HP:0000486 | Strabismus |
GWAS associations
9 associations (top):
| Study | Trait | p-value |
|---|---|---|
| GCST002454_12 | Colorectal cancer | 1.000000e-08 |
| GCST004898_3 | Preterm birth (maternal effect) | 5.000000e-07 |
| GCST005194_185 | Coronary artery disease | 4.000000e-17 |
| GCST005195_126 | Coronary artery disease | 2.000000e-17 |
| GCST005196_238 | Coronary artery disease | 4.000000e-16 |
| GCST007096_256 | Pulse pressure | 2.000000e-08 |
| GCST007856_49 | Colorectal cancer or advanced adenoma | 1.000000e-06 |
| GCST010480_17 | Coronary artery disease | 7.000000e-09 |
| GCST010480_23 | Coronary artery disease | 9.000000e-09 |
EFO canonical traits (3, from GWAS)
| EFO ID | Trait name |
|---|---|
| EFO:0003917 | premature birth |
| EFO:0005939 | parental genotype effect measurement |
| EFO:0005763 | pulse pressure measurement |
Drugs & pharmacology
Drug and pharmacology data
Is drug target: no
PharmGKB: 1 entry (VIP=true, CPIC=false)
PharmGKB variants
1 variants.
| Variant | Genes | Level | Score | #Clin annots | Drugs |
|---|---|---|---|---|---|
| rs1800469 | B9D2, TGFB1, TMEM91 | 3 | 2.50 | 2 | aspirin;irinotecan |
CTD chemical–gene interactions
14 total (human), top 14 by PubMed support.
| Chemical | Actions (top 5) | PubMed papers |
|---|---|---|
| Air Pollutants | increases abundance, increases expression, decreases expression | 2 |
| Smoke | decreases expression, increases abundance, increases expression | 2 |
| triphenyl phosphate | affects expression | 1 |
| tris(1,3-dichloro-2-propyl)phosphate | decreases expression | 1 |
| sodium arsenite | decreases expression | 1 |
| 2,6-dichloro-(1,4)benzoquinone | increases expression | 1 |
| Temozolomide | increases expression | 1 |
| Arsenic | affects methylation | 1 |
| Benzo(a)pyrene | increases methylation | 1 |
| Rotenone | decreases expression | 1 |
| Dronabinol | decreases expression | 1 |
| Tobacco Smoke Pollution | decreases expression | 1 |
| Antirheumatic Agents | decreases expression | 1 |
| Particulate Matter | decreases expression, increases abundance | 1 |
Clinical trials (associated diseases)
4 trials via MONDO — disease-level, not drug-specific.
| Trial | Phase | Status | Title |
|---|---|---|---|
| NCT01401998 | Not specified | RECRUITING | ARPKD Database Study |
| NCT00068224 | Not specified | COMPLETED | Clinical and Molecular Investigations Into Ciliopathies |
| NCT04874909 | Not specified | COMPLETED | Classification, Functional Stratification and Biomarkers in Ciliopathy (CILLICORIRCM) |
| NCT00873678 | Not specified | COMPLETED | Assessment of the Prevalence of Genes AHI1, NPHP1 and CEP290 in Joubert Syndrome |
Related Atlas pages
- Associated diseases: Meckel syndrome, type 10, Meckel syndrome, type 1, ciliopathy
- Disease cohort memberships (association, not causation — diseases whose associated-gene cohort lists this gene; a subset are also under Associated diseases): ciliopathy, colorectal adenoma, Joubert syndrome, Joubert syndrome 34, Joubert syndrome and related disorders, Meckel syndrome, Meckel syndrome, type 10